… -aided drug design in the context of COVID-19 … drug candidate molecules against various
drug targets implicated in the pathogenesis of severe acute respiratory syndrome coronavirus …

… explore structure-assisted drug design strategies and inhibitors to target COVID-19 M pro
. … drug targets and anti-COVID-19 drugs (by drug repurposing). Mechanisms of COVID-19-…

… , within an AI framework will help the in silico drug design process to be faster and less costly,
… for COVID-19 Antiviral Molecule Design. Given the urgency with the ongoing COVID19 …

… the structure-based design of a preliminary drug candidate against COVID-19 using free …
-based drug design and to allow others to unleash their own creativity to design new drugs to …

… To test the performance of our model for COVID-19 drug design, we consider a SARS-CoV
BA dataset, which contains 185 |$M^{pro}$|-ligand complexes and their experimental binding …

… A new coronavirus (CoV) identified as COVID-19 virus is the … drug design, virtual drug
screening and high-throughput screening to identify new drug leads that target the COVID-19 virus …

… To find effective molecules for COVID-19 inhibition, we have quantitatively investigated
143 X-ray crystal structures of the SARS-CoV-2 M pro protein of coronavirus with covalently or …

… global COVID-19 pandemic (as WHO's declaration) and the high demand for new drug …
recently is considered for structure-based drug design efforts. To make screening effective and …

… de novo drug design for COVID-19 pharmaceutical research. … , repurpose drugs, find novel
drug targets, and design novel … of de novo drug design since the COVID-19 pandemic started. …

… Coronavirus family which caused the worldwide pandemic of human respiratory illness
coronavirus disease 2019 (COVID-19)… to date, about twenty COVID-19 vaccines approved for use …